USA. U. S. spends $5 billion to accelerate development of new COVID-19 vaccines

WASHINGTON DC. (AP) — The U. S. is spending more than $5 billion to fuel the progression of new COVID-19 vaccines and treatments, a Department of Health and Human Services spokesman and a Biden administration official said Monday, April 10.

The investment, dubbed “Project NextGen” and first announced by White House and HHS officials in an interview with The Washington Post, aims to offer greater coverage against coronaviruses, adding that which causes COVID-19, which could be only a long-term threat. .

“While our vaccines remain very effective at preventing serious illness and death, they are less able to reduce infections and transmission over time,” the HHS spokesperson said.

“New variants and loss of immunity over time may continue to challenge our fitness systems for years to come. “

President Joe Biden’s management will spend at least $5 billion on collaborations with the personal sector, a technique for the allocation of “Operation Warp Speed” under former President Donald Trump that accelerated vaccine progression and distribution in 2020.

“The NextGen allocation will drive and accelerate the immediate progression of next-generation public-private partnerships and remedies,” the management official said.

“Injecting an investment of at least $5 billion will help catalyze clinical progress in spaces that have significant public fitness benefits for the American people, in order to develop effective equipment for the American people. “

The project, which is expected to be at HHS, will be coordinated within the government and with the personal sector to advance a pipeline of new vaccines and treatments, the HHS spokesperson said. It will cover all stages of development, from laboratory studies to clinical trials. to deliver.

It will focus on creating durable monoclonal antibodies resistant to new COVID-19 variants, as well as broader vaccines that can oppose several other coronaviruses.

The task also aims to boost the progression of vaccines that produce immunity in the mucous membranes and can be administered through the nose, in the hope that they can increase infection and transmission rates Rappler. com.

Leave a Comment

Your email address will not be published. Required fields are marked *